Ed Chen

Ed Chen is an accomplished professional in the pharmaceutical industry with extensive experience in drug substance operations and CMC management. Currently serving as Senior Director at Graviton Bioscience, Ed oversees a global network of CROs and CMOs for drug substance manufacturing. Previously, Ed held key roles at Perspective Therapeutics as Director of CMC Operations, TG Therapeutics as Director of CMC Drug Substance Operations, and Recordati Rare Diseases as a Consultant in Technical Operations. With a strong foundation in organic chemistry, including a Ph.D. from Rutgers University, Ed has demonstrated exceptional leadership in project management, manufacturing process optimization, and regulatory compliance across various organizations, significantly contributing to the development and commercialization of pharmaceutical products.